ZYGEL
DEAD

Serial Number

87571145

Owner

Zynerba Pharmaceuticals, Inc.

Attorney

Sarah Anne Keefe

Filing Date

Aug 16, 2017

Add to watchlist:

No watchlists yet
View on USPTO

ZYGEL Trademark

Serial Number: 87571145

ZYGEL is a trademark filed by Zynerba Pharmaceuticals, Inc. on August 16, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Zynerba Pharmaceuticals, Inc. (9 trademarks)

Suite 300
Devon, PA 19333

Entity Type: 03

Trademark Details

Filing Date

August 16, 2017

Registration Date

Not Registered

Published for Opposition

December 26, 2017

Goods & Services

Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech disorders and diseases, traumatic brain injury, and viral diseases and disorders; Pharmaceutical preparations for the treatment of fragile x syndrome, substance related addiction, autism and autism spectrum disorders, epilepsy, seizure diseases and disorders, anxiety, aphasias, stuttering, post-traumatic stress disorder; all of the foregoing specifically excluding narcolepsy and management of sleep disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 7, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 7, 2022 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 13, 2021 EXRA
SOU EXTENSION 5 GRANTED
Jul 12, 2021 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 8, 2021 AITU
SOU EXTENSION 5 FILED
Jun 30, 2021 EXT5
SOU TEAS EXTENSION RECEIVED
Jun 30, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 6, 2021 EXRA
SOU EXTENSION 4 GRANTED
Jan 4, 2021 EX4G
SOU EXTENSION 4 FILED
Jan 4, 2021 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 4, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 10, 2020 EXRA
SOU EXTENSION 3 GRANTED
Jun 8, 2020 EX3G
SOU EXTENSION 3 FILED
Jun 8, 2020 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 8, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 30, 2020 EXRA
SOU EXTENSION 2 GRANTED
Jan 28, 2020 EX2G
SOU EXTENSION 2 FILED
Jan 28, 2020 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 28, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 23, 2019 EXRA
SOU EXTENSION 1 GRANTED
Jul 19, 2019 EX1G
SOU EXTENSION 1 FILED
Jul 19, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 19, 2019 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 29, 2019 NOAM
TTAB RELEASE CASE TO TRADEMARKS
Dec 12, 2018 TMBN
OPPOSITION TERMINATED NO. 999999
Dec 12, 2018 OP.T
OPPOSITION DISMISSED NO. 999999
Dec 12, 2018 OP.D
OPPOSITION INSTITUTED NO. 999999
Apr 25, 2018 OP.I
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 14, 2018 TCCA
ASSIGNED TO EXAMINER
Jan 31, 2018 DOCK
EXTENSION OF TIME TO OPPOSE RECEIVED
Jan 25, 2018 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 26, 2017 NPUB
PUBLISHED FOR OPPOSITION
Dec 26, 2017 PUBO
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 6, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 6, 2017 REAP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 6, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 20, 2017 CNSA
ASSIGNED TO EXAMINER
Nov 20, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 22, 2017 NWOS
NEW APPLICATION ENTERED
Aug 21, 2017 NWAP